Esperion Therapeutics (NASDAQ:ESPR) General Counsel Sells $17,547.60 in Stock
MarketBeat
Esperion Therapeutics, Inc. (NASDAQ:ESPR - Get Free Report) General Counsel Benjamin Looker sold 6,267 shares of the stock in a transaction dated Wednesday, September 17th. The shares were sold at an average price of $2.80, for a total value of $17,547.60. Following the completion of the transaction, the general counsel directly owned 393,670 shares in the company, valued at approximately $1,102,276. This represents a 1.57% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.
NASDAQ:ESPR